IL165240A0 - Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemorsistance - Google Patents

Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemorsistance

Info

Publication number
IL165240A0
IL165240A0 IL16524003A IL16524003A IL165240A0 IL 165240 A0 IL165240 A0 IL 165240A0 IL 16524003 A IL16524003 A IL 16524003A IL 16524003 A IL16524003 A IL 16524003A IL 165240 A0 IL165240 A0 IL 165240A0
Authority
IL
Israel
Prior art keywords
chemorsistance
predict
gene expression
differential patterns
chemosensitivity
Prior art date
Application number
IL16524003A
Other languages
English (en)
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of IL165240A0 publication Critical patent/IL165240A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16524003A 2002-05-17 2003-05-16 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemorsistance IL165240A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38114102P 2002-05-17 2002-05-17
PCT/US2003/015691 WO2004035805A2 (en) 2002-05-17 2003-05-16 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemoresistance

Publications (1)

Publication Number Publication Date
IL165240A0 true IL165240A0 (en) 2005-12-18

Family

ID=32107802

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16524003A IL165240A0 (en) 2002-05-17 2003-05-16 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemorsistance

Country Status (10)

Country Link
US (1) US20040018527A1 (ja)
EP (1) EP1576177A4 (ja)
JP (1) JP2006505256A (ja)
AU (1) AU2003301458A1 (ja)
CA (1) CA2486105A1 (ja)
IL (1) IL165240A0 (ja)
MX (1) MXPA04011424A (ja)
RU (1) RU2004136990A (ja)
WO (1) WO2004035805A2 (ja)
ZA (1) ZA200409189B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7465542B2 (en) * 2002-10-15 2008-12-16 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for determining risk of treatment toxicity
WO2005118858A1 (en) * 2004-05-28 2005-12-15 Board Of Regents, The University Of Texas System Multigene predictors of response to chemotherapy
US20090215641A1 (en) * 2005-08-12 2009-08-27 Nihon University Gene involved in occurrence/recurrence of hcv-positive hepatocelluar carcinoma
US20080085243A1 (en) * 2006-10-05 2008-04-10 Sigma-Aldrich Company Molecular markers for determining taxane responsiveness
WO2011065533A1 (ja) * 2009-11-30 2011-06-03 国立大学法人大阪大学 乳癌術前化学療法に対する感受性の判定方法
US20130130928A1 (en) 2010-04-08 2013-05-23 Institut Gustave Roussy Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5119827A (en) * 1990-09-05 1992-06-09 Board Of Regents, The University Of Texas System Mechanisms of antiestrogen resistance in breast cancer
US5645988A (en) * 1991-05-08 1997-07-08 The United States Of America As Represented By The Department Of Health And Human Services Methods of identifying drugs with selective effects against cancer cells
AU692434B2 (en) * 1993-01-21 1998-06-11 President And Fellows Of Harvard College Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound
US6136587A (en) * 1995-07-10 2000-10-24 The Rockefeller University Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof
US20020006613A1 (en) * 1998-01-20 2002-01-17 Shyjan Andrew W. Methods and compositions for the identification and assessment of cancer therapies
US6107034A (en) * 1998-03-09 2000-08-22 The Board Of Trustees Of The Leland Stanford Junior University GATA-3 expression in human breast carcinoma
US6203987B1 (en) * 1998-10-27 2001-03-20 Rosetta Inpharmatics, Inc. Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns
US6759238B1 (en) * 1999-03-31 2004-07-06 St. Jude Children's Research Hospital Multidrug resistance associated proteins and uses thereof
US6635423B2 (en) * 2000-01-14 2003-10-21 Integriderm, Inc. Informative nucleic acid arrays and methods for making same
WO2001061050A2 (en) * 2000-02-17 2001-08-23 Millennium Pharmaceuticals, Inc. Methods and compositions for the identification, assessment, prevention and therapy of human cancers
WO2001073430A2 (en) * 2000-03-24 2001-10-04 Millennium Pharmaceuticals, Inc. Identification, assessment, prevention and therapy of cancers
AU2001251613A1 (en) * 2000-04-14 2001-10-30 Millennum Pharmaceuticals, Inc. Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers
US20020015956A1 (en) * 2000-04-28 2002-02-07 James Lillie Compositions and methods for the identification, assessment, prevention, and therapy of human cancers
US6368806B1 (en) * 2000-10-05 2002-04-09 Pioneer Hi-Bred International, Inc. Marker assisted identification of a gene associated with a phenotypic trait
WO2003000189A2 (en) * 2001-06-21 2003-01-03 Baylor College Of Medicine Prediction, diagnosis and treatment of endocrine resistant breast cancer, using p38 mapk pathway

Also Published As

Publication number Publication date
WO2004035805A3 (en) 2006-02-16
MXPA04011424A (es) 2005-02-17
WO2004035805A2 (en) 2004-04-29
EP1576177A4 (en) 2007-12-26
EP1576177A2 (en) 2005-09-21
RU2004136990A (ru) 2005-08-10
JP2006505256A (ja) 2006-02-16
CA2486105A1 (en) 2004-04-29
US20040018527A1 (en) 2004-01-29
AU2003301458A1 (en) 2004-05-04
ZA200409189B (en) 2006-03-29

Similar Documents

Publication Publication Date Title
GB2420679B (en) Processing of computer graphics
AU2003293132A8 (en) Integration of gene expression data and non-gene data
HK1085244A1 (en) Quantification of gene expression
GB0403705D0 (en) Gaming facility and method of operation thereof
DE60336405D1 (de) Dreiteilige einwegunterwäsche und herstellungsverfahren dafür
PL2141173T3 (pl) Sposoby i kompozycje do hamowania ekspresji genów
HK1179304A1 (en) Method and compositions for detection and enumeration of genetic variations
SG113597A1 (en) Method of restoring dimensions of an airfoil and preform for performing same
IL169440A0 (en) Drug-coated stents and methods of use therefor
EP1793767A4 (en) SELF-RESTRICTED, SEGMENTED STENTS AND DEVELOPMENT METHODS THEREFOR
EP1687789A4 (en) PROCESS FOR PUBLISHING AND DISTRIBUTION OF EDUCATIONAL MATERIAL
EP1534840A4 (en) NEW SIRNA GENIUS LIBRARIES AND METHOD FOR THEIR MANUFACTURE AND USE
GB2428159B (en) Computer Hologram And Creation Method Thereof
EP1542079A4 (en) COATING FORMING AGENT FOR REDUCING THE PATTERN DIMENSION AND METHOD FOR FORMING THE END PATTERN
TWI316165B (en) Over-coating agent for forming fine patterns and a method of forming fine patterns using such agent
AU2003273332A8 (en) Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
GB2435791B (en) Illuminated clipboard and method of use
IL165240A0 (en) Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemorsistance
GB0404954D0 (en) An aparatus and method for flood defence
EP1650301A4 (en) THE RE-IDENTIFICATION OF A PLANT AWARDING GENE AND USE THEREOF
EP1640045A4 (en) GAME MACHINE AND METHOD OF CONTROLLING A COMPUTER
GB2444598B (en) Processing of computer graphics
AU2003272625A8 (en) Mono-column floating platform and method of installing same
GB0720997D0 (en) Methods of altering gene expression and methods of treatment utilizing same
AU2003292312A8 (en) Method for simulation and digital synthesis of an oscillating phenomenon